RYTM
NASDAQ · Biotechnology
Rhythm Pharmaceuticals Inc
$94.17
-2.06 (-2.14%)
Performance
1D
—
1W
—
1M
—
3M
-8.46%
6M
-3.83%
1Y
+59.70%
YTD
-10.32%
Open$95.79
Previous Close$96.23
Day High$96.76
Day Low$93.24
52W High$122.20
52W Low$55.31
Volume—
Avg Volume799.4K
Market Cap6.45B
P/E Ratio—
EPS$-3.03
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$105.86
Below
SMA 200
$92.90
Above
RSI (14)
49.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+7.3% upside
Current
$94.17
$94.17
Target
$101.09
$101.09
$80.78
$101.09 avg
$123.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 200.12M | 975.71M | 873.25M |
| Net Income | -207,270,029 | -22,144,056 | -23,253,892 |
| Profit Margin | -103.6% | -2.3% | -2.7% |
| EBITDA | -199,758,855 | -26,213,634 | -24,112,007 |
| Free Cash Flow | — | -20,824,615 | -25,629,049 |
| Rev Growth | +100.2% | -2.7% | +8.2% |
| Debt/Equity | 0.40 | 0.40 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |